CNS & Neurological Disorders - Drug Targets
Title:Editorial (Hot Topic: Model System Caenorhabditis elegans and Neurodegenerative Disease Research)
Volume: 11 Issue: 8
Author(s): Aamir Nazir
Affiliation:
Export Options
About this article
Cite this article as:
Nazir Aamir, Editorial (Hot Topic: Model System Caenorhabditis elegans and Neurodegenerative Disease Research), CNS & Neurological Disorders - Drug Targets 2012; 11 (8) . https://dx.doi.org/10.2174/1871527311211080003
DOI https://dx.doi.org/10.2174/1871527311211080003 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
31
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diagnostic Boundaries of Autism Disorder Vs Pervasive Developmental Disorder Nos Comparative Observational Study and Literature Review
Current Clinical Pharmacology Adoptive Regulatory T-cell Therapy Attenuates Subarachnoid Hemor-rhage-induced Cerebral Inflammation by Suppressing TLR4/NF-B Signaling Pathway
Current Neurovascular Research HIV Risk Behavior and Prevention Considerations Among Military Personnel in Three Caribbean Region Countries: Belize, Barbados, and the Dominican Republic
Current HIV Research The Vitamin D Saga: Breaking Dawn
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Protein Interactions Between the C-Terminus of Aβ-Peptide and Phospholipase A<sub>2</sub> - A Structure Biology Based Approach to Identify Novel Alzheimer's Therapeutics
CNS & Neurological Disorders - Drug Targets Energizing Genetics and Epi-genetics: Role in the Regulation of Mitochondrial Function
Current Genomics Neural Mechanisms of Exercise: Anti-Depression, Neurogenesis, and Serotonin Signaling
CNS & Neurological Disorders - Drug Targets Adult Stem Cells and Mammalian Epimorphic Regeneration-Insights from Studying Annual Renewal of Deer Antlers
Current Stem Cell Research & Therapy PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design Functional Role of β-Turn in Polypeptide Structure and its use as Template to Design Therapeutic Agents
Central Nervous System Agents in Medicinal Chemistry Peripheral TRPV1 Receptors As Targets for Drug Development: New Molecules and Mechanisms
Current Pharmaceutical Design Epicardial Adipose Tissue As New Cardio-Metabolic Risk Marker and Potential Therapeutic Target in the Metabolic Syndrome
Current Pharmaceutical Design Transthyretin Decrease in Plasma of MCI and AD Patients: Investigation of Mechanisms for Disease Modulation
Current Alzheimer Research The Novel Multi-Target Iron Chelator, M30 Modulates HIF-1α-Related Glycolytic Genes and Insulin Signaling Pathway in the Frontal Cortex of APP/PS1 Alzheimer’s Disease Mice
Current Alzheimer Research A Rationale for Curcuminoids for the Prevention or Treatment of Alzheimers Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Therapeutical Potential of Alpha-Synuclein Antiaggregatory Agents for Dementia with Lewy Bodies
Current Medicinal Chemistry Challenges in Neuronal Apoptosis
Current Alzheimer Research Involvement of Mast Cells in Angiogenesis and Chronic Inflammation
Current Drug Targets - Inflammation & Allergy In Vitro and In Silico Studies of Glycyrrhetinic Acid Derivatives as Anti- Filarial Agents
Current Topics in Medicinal Chemistry Recent Patents and Trends in Orally Disintegrating Tablets
Recent Patents on Drug Delivery & Formulation